These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28681114)

  • 1. Predicting the Correlation of EZH2 and Cancer Stem Cell Markers in Esophageal Squamous Cell Carcinoma.
    Karami Madani G; Rad A; Molavi M; Ardalan Khales S; Abbaszadegan MR; Forghanifard MM
    J Gastrointest Cancer; 2018 Dec; 49(4):437-441. PubMed ID: 28681114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma.
    Zargari S; Negahban Khameneh S; Rad A; Forghanifard MM
    BMC Cancer; 2020 Aug; 20(1):789. PubMed ID: 32819319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2.
    You BH; Yoon JH; Kang H; Lee EK; Lee SK; Nam JW
    Proc Natl Acad Sci U S A; 2019 Dec; 116(49):24620-24629. PubMed ID: 31732666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWIST1 correlates with Notch signaling pathway to develop esophageal squamous cell carcinoma.
    Fahim Y; Yousefi M; Izadpanah MH; Forghanifard MM
    Mol Cell Biochem; 2020 Nov; 474(1-2):181-188. PubMed ID: 32712748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.
    Wang W; Zhu Y; Li S; Chen X; Jiang G; Shen Z; Qiao Y; Wang L; Zheng P; Zhang Y
    Oncotarget; 2016 May; 7(18):25668-82. PubMed ID: 27015363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
    Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M
    Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
    Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
    Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 regulates oncomiR-200c and EMT markers in esophageal squamous cell carcinomas.
    Nourmohammadi F; Forghanifard MM; Abbaszadegan MR; Zarrinpour V
    Sci Rep; 2022 Oct; 12(1):18290. PubMed ID: 36316365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic expression of TWIST1 upregulates the stemness marker OCT4 in the esophageal squamous cell carcinoma cell line KYSE30.
    Izadpanah MH; Abbaszadegan MR; Fahim Y; Forghanifard MM
    Cell Mol Biol Lett; 2017; 22():33. PubMed ID: 29299035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
    Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
    Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
    [No Abstract]   [Full Text] [Related]  

  • 12. EZH2 deregulates BMP, Hedgehog, and Hippo cell signaling pathways in esophageal squamous cell carcinoma.
    Ardalan Khales S; Forghanifard MM; Abbaszadegan MR; Hosseini SE
    Adv Med Sci; 2023 Mar; 68(1):21-30. PubMed ID: 36403545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma.
    Ding X; Qi C; Min J; Xu Z; Huang K; Tang H
    J Cell Mol Med; 2020 Sep; 24(18):10551-10559. PubMed ID: 32729661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
    Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
    Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation.
    Mochizuki D; Misawa Y; Kawasaki H; Imai A; Endo S; Mima M; Yamada S; Nakagawa T; Kanazawa T; Misawa K
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus.
    Yamada A; Fujii S; Daiko H; Nishimura M; Chiba T; Ochiai A
    Int J Oncol; 2011 Feb; 38(2):345-53. PubMed ID: 21165554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
    Cheng T; Xu Y
    Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway.
    Chen M; Xia Z; Chen C; Hu W; Yuan Y
    Anticancer Drugs; 2018 Sep; 29(8):767-773. PubMed ID: 29916899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter.
    van Vlerken LE; Kiefer CM; Morehouse C; Li Y; Groves C; Wilson SD; Yao Y; Hollingsworth RE; Hurt EM
    Stem Cells Transl Med; 2013 Jan; 2(1):43-52. PubMed ID: 23283488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.